Design, Formulation and Testing of Systemically Dosed Peptide and Polymer DNA and mRNA Nanoparticles Published 2018-12-07 Download video MP4 360p Recommendations 25:57 Design and Translational Application of HSV Gene Vectors in Nervous System Diseases 09:41 Common cell signaling pathway 03:13 AAV Expression Cassette 53:14 ASGCT & HFA Webinar Series: Gene Therapy Basics 56:46 Gene Editing Technologies: Transforming Rare Disease Care 09:48 Cirrhosis - causes, symptoms, diagnosis, treatment, pathology 35:04 AAV Capsid Production with Drs. Mario Mietzsch and Robert McKenna - Molecular Therapy Podcast 44:13 CAR T for Acute Myeloid Leukemia with Dr. Marco Davila—Molecular Therapy Podcast 03:10 How could gene therapy reduce the need for eye injections? 14:28 An Osmosis Video: Congestive Heart Failure (CHF) Explained 09:01 Type I hypersensitivity (IgE-mediated hypersensitivity) - causes, symptoms, pathology 01:26 Lentivirus Vectors for Gene Therapy for Hemophilia 48:15 Gene Insertion Tech with Jason Cole, CEO of SalioGen—ASGCT's The Issue 12:28 Rheumatoid arthritis - causes, symptoms, diagnosis, treatment, pathology 02:01 Gene therapy: bringing new hope to people with vision loss 13:42 Cushing Syndrome - causes, symptoms, diagnosis, treatment, pathology 13:40 Ischemic Stroke - causes, symptoms, diagnosis, treatment, pathology Similar videos 37:28 Formulation of biological drugs using nanotechnology approaches 53:34 Lipid nanoparticles for mRNA delivery 31:06 2021 Annual mRNA Day- Dan Anderson: Nucleic Acid Delivery Systems for RNA Therapy and Genome Editing 52:24 Automated Lipid Nanoparticle Formulation Library Generation for Vaccine Development 1:28:39 Functional Nanoparticles for Biosensing Drug Delivery | Prof Irshad Hussain | YPS | STEMatters 34:40 Facing the challenge of reproducible and scalable nanoparticle production for RNA delivery 22:54 Degradable Polymer Nanoparticles for the Treatment of Brain Tumors 27:55 Nucleic Acid Delivery Systems for RNA Therapy and Gene Editing - Daniel Anderson 1:51:07 24. Beyond LNPs RNA Formulation & Drug Delivery and Diagnosis during COVID: Ongoing Developments 25:00 Oligonucleotide therapeutic development: Pre-clinical and translational considerations 59:31 eTheRNA’s mRNA Lipid Nanoparticles LNP Technology Developed for its Cancer Immunotherapy Programs 59:07 2022 Paul D. Bartlett, Sr. Lecture - Biomedical Engineering and Medicines of the Future 1:01:50 In Vivo RNAi -- Considerations and Examples; a Panel Presentation 1:46:38 Development of mRNA vaccines and therapies 32:48 Shaukat Ali | Keynote Speaker | Pharmaceutics 2022 | 14-15 November 2022 | Dubai, UAE and Online More results